Benzinga | May 6, 2021 05:05PM EDT

Chembio Diagnostics Q1 EPS $(0.22) Beats $(0.32) Estimate, Sales $8.70M Beat $8.19M Estimate

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.32) by 31.25 percent. This is a 12 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $8.70 million which beat the analyst consensus estimate of $8.19 million by 6.23 percent. This is a 26.82 percent increase over sales of $6.86 million the same period last year.